Laššuthová P, Brožková D Šafka, Krůtová M, Neupauerová J, Haberlová J, Mazanec R, Dvořáčková N, Goldenberg Z, Seeman P
DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, V Úvalu 84, 150 06, Prague, Czech Republic,
Neurogenetics. 2015 Jan;16(1):43-54. doi: 10.1007/s10048-014-0427-8. Epub 2014 Oct 24.
Mutations in the HINT1 gene were recently discovered as being the major cause of autosomal recessive axonal neuropathy with neuromyotonia. This combination was clinically recognized and described previously in a few reports but is generally unknown. We aimed to establish the importance of HINT1 mutations as the cause of hereditary neuropathy and particularly hereditary motor neuropathy/axonal Charcot-Marie-Tooth (HMN/CMT2) among Czech patients. Overall, mutations in the HINT1 gene seem to be a surprisingly frequent cause of inherited neuropathy in our group of patients. Biallelic pathogenic mutations were found in 21 patients from 19 families. The prevalent mutation in the Czech population is the p.R37P (95% of pathogenic alleles). Clinically, all patients with biallelic mutations presented with early onset of symptoms at the end of the first decade. Foot/toe extension weakness to plegia was present in almost all patients. Neuromyotonia was present in all but two patients. However, it had been properly recognized in only three patients prior to molecular genetic diagnosis. HINT1 mutations seem to be one of the most frequent causes of inherited neuropathy and are probably the most frequent cause of HMN in Czech patients. We suggest all HMN/CMT2 patients be tested for the presence of the prevalent mutation, the p.R37P.
HINT1基因的突变最近被发现是导致常染色体隐性遗传性轴索性神经病伴神经肌强直的主要原因。这种综合征在之前的一些报告中已有临床认识和描述,但总体上并不为人所知。我们旨在确定HINT1突变作为遗传性神经病,尤其是捷克患者中遗传性运动神经病/轴索性夏科-马里-图斯病(HMN/CMT2)病因的重要性。总体而言,HINT1基因的突变在我们的患者群体中似乎是遗传性神经病出人意料的常见病因。在来自19个家庭的21名患者中发现了双等位基因致病性突变。捷克人群中最常见的突变是p.R37P(占致病性等位基因的95%)。临床上,所有双等位基因突变患者在第一个十年末均出现早期症状。几乎所有患者都存在足/趾背伸无力至瘫痪。除两名患者外,所有患者均有神经肌强直。然而,在分子遗传学诊断之前,只有三名患者得到了正确诊断。HINT1突变似乎是遗传性神经病最常见的病因之一,可能是捷克患者中HMN最常见的病因。我们建议对所有HMN/CMT2患者进行常见突变p.R37P的检测。